| Patents for C07H 17 - Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals (11,681) |
|---|
| 06/15/2000 | WO2000006531A3 Nitric esters and nitrate salts of specific drugs |
| 06/15/2000 | CA2351059A1 Acylated benzylmaltosides as inhibitors of smooth muscle cell proliferation |
| 06/14/2000 | EP1007530A1 6-o-substituted erythromycin compounds and method for making same |
| 06/13/2000 | US6075133 Increased acid stability and enhanced bactericidal activity |
| 06/13/2000 | US6075011 6-O-substituted erythromycin compounds and method for making same |
| 06/08/2000 | WO2000032203A1 Ethanolate of azithromycin, process for manufacture, and pharmaceutical compositions thereof |
| 06/08/2000 | CA2352562A1 Ethanolate of azithromycin, process for manufacture, and pharmaceutical compositions thereof |
| 06/07/2000 | EP1005356A1 Novel antibacterial agents |
| 06/07/2000 | CN1053193C Esculetin derivatives, process for manufacture and use thereof, and pharmaceutical compsn. |
| 06/07/2000 | CN1053192C Method for refining rutin |
| 06/06/2000 | US6072052 Method for the production of ivermectin |
| 06/06/2000 | US6071886 β,β-distributed derivatives of 9-deoxo-9a-N-ethenyl-9a-aza-9a-homoerythromycin A |
| 06/02/2000 | WO2000031099A1 Novel intermediates, process for preparing macrolide antibiotic agent therefrom |
| 06/02/2000 | WO2000031097A1 13-membered azalides and their use as antibiotic agents |
| 06/02/2000 | CA2352162A1 Novel intermediates, process for preparing macrolide antibiotic agent therefrom |
| 05/31/2000 | EP1004592A1 Derivatives of erythromycin, their process of preparation and their application as medicaments |
| 05/31/2000 | EP1004591A1 Process for preparing roxithromycin and derivatives thereof |
| 05/31/2000 | EP1003764A1 Improved process for antiparasitic agent |
| 05/31/2000 | EP1003760A1 Prodrugs and conjugates of thiol- and selenol- containing compounds and methods of use thereof |
| 05/31/2000 | EP1003541A1 Inhibitors of hiv reverse transcriptase |
| 05/31/2000 | CN1052984C New erythromycin derivative and its preparing process and application in medicine |
| 05/31/2000 | CN1052983C Melim sulfate compound |
| 05/30/2000 | US6069238 For use as chemical intermediates for the efficient, high yield preparation of papulacandin compounds and analogs, which are antibiotics/fungicides |
| 05/30/2000 | US6068859 Controlled-release dosage forms of Azithromycin |
| 05/24/2000 | EP1001962A1 Production of avermectin compounds |
| 05/24/2000 | EP1001797A1 Soya extract, process for its preparation and pharmaceutical composition |
| 05/24/2000 | EP0787135B1 Water-soluble epipodophyllotoxin derivatives, preparation method therefor, and use thereof as a drug and for treating cancer |
| 05/23/2000 | US6066721 Method to produce novel polyketides |
| 05/23/2000 | US6066312 Skin-lightening and whitening effects |
| 05/18/2000 | WO2000027857A2 Novel erythromycin derivatives, preparation method and use as medicines |
| 05/18/2000 | WO2000027856A1 Macrolide intermediates |
| 05/17/2000 | EP1000952A2 New 2-halogenated derivatives of 5-O-deosaminylerythronolide A, process for making them as well as their use as medicines |
| 05/17/2000 | EP1000079A1 New formulation |
| 05/17/2000 | EP1000077A1 Synthetic insulin mimetic substances |
| 05/17/2000 | EP1000042A1 Fluorescent dibenzazole derivatives and methods related thereto |
| 05/17/2000 | CN1052488C Technology for one-step synthesizing miocamycin |
| 05/16/2000 | US6063787 Methods for the treatment of psoriasis and genital warts |
| 05/16/2000 | US6063561 Erythromycin derivatives in which methyl groups on the macrolactone ring are substituted with hydrogen, ethyl and/or hydroxy groups and the ethyl side-chain has been substituted with hydroxymethyl or dihydroxycyclohexylmethyl side-chains |
| 05/16/2000 | CA2191920C Derivatives of 3-deoxy 16-membered ring macrolide antibiotics |
| 05/11/2000 | WO2000026399A2 Method for the production of quercetin and isoquercetin derivatives |
| 05/11/2000 | WO2000026224A2 Novel macrolide antibiotics |
| 05/11/2000 | WO2000025764A2 Compositions for the treatment and prevention of cardiovascular diseases |
| 05/11/2000 | CA2348728A1 Method for the production of quercetin and isoquercetin derivatives |
| 05/10/2000 | EP0925065A4 Water miscible erythromycin solutions |
| 05/10/2000 | CN1252276A Medicament containing 1-(2'-gamma-pyrone)-6-caffacyl-B-D-pyranoglucoside and its preparation |
| 05/10/2000 | CN1052236C Process for prepn. of ivermectin |
| 05/10/2000 | CN1052235C Intermediate for preparing glucoside podophyllum ethyldene phosphate ester |
| 05/09/2000 | US6060453 Immunomodulatory, anti-inflammatory, and anti-proliferative compounds: 5,6-dideoxy, 5-amino derivatives of idose and 6-deoxy, 6-amino derivatives of glucose |
| 05/09/2000 | US6060234 Novel erythromycin derivatives in which methyl groups on the macrolactone ring have been substituted with hydrogen, ethyl, and/or hydroxy groups |
| 05/04/2000 | WO2000024907A2 Library of novel "unnatural" natural products |
| 05/04/2000 | WO2000024753A1 Chromogenic substrates of sialidase and methods of making and using the same |
| 05/04/2000 | WO2000024403A1 Use of antifungal agents for treating scleroses |
| 05/04/2000 | WO2000024402A1 Use of antifungal agents for treating scleroses |
| 05/04/2000 | WO2000006606A3 Erythromycin derivatives with antibiotic activity |
| 05/04/2000 | WO1999063988A9 Inhibitors of nitric oxide synthase |
| 05/04/2000 | DE19850572A1 Preparation of new or known luteolin compounds by reducing flavonoids with sodium dithionite, used e.g. as nutritional supplements, cosmetic UV filters or cardiovascular drugs |
| 05/04/2000 | DE19850282A1 Preparation of new or known tris-hydroxyalkyl quercetin and isoquercetin derivatives by enzymatic cleavage of rutin derivatives, used e.g. as nutritional supplements, cosmetic UV filters or cardiovascular drugs |
| 05/04/2000 | CA2348160A1 Use of antifungal agents for treating scleroses |
| 05/04/2000 | CA2347128A1 Library of novel "unnatural" natural products |
| 05/04/2000 | CA2311387A1 Chromogenic substrates of sialidase and methods of making and using the same |
| 05/03/2000 | EP0997472A2 Spirocyclic C-glycosides |
| 05/03/2000 | EP0997471A2 Process for the preparation of glycosides |
| 05/03/2000 | EP0996714A2 Method to produce polyketides , polyketides |
| 04/27/2000 | WO2000023081A1 Derivatives of erythromycin, clarithromycin, roxithromycin or azithromycin with antibiotic and mucolytic activity |
| 04/27/2000 | WO2000000618A3 Polyketides and their synthesis |
| 04/27/2000 | CA2346870A1 Derivatives of erythromycin, clarithromycin, roxithromycin or azithromycin with antibiotic and mucolytic activity |
| 04/27/2000 | CA2346325A1 Bioflavonoids as plasma high density lipoprotein level increasing agent |
| 04/26/2000 | EP0994889A2 Erythromycin a oxime solvates |
| 04/25/2000 | US6054435 6-O-substituted macrolides having antibacterial activity |
| 04/25/2000 | US6054434 8a-azalides as veterinary antimicrobal agents |
| 04/20/2000 | WO1999040097A8 Process for making clarithromycin |
| 04/19/2000 | CN1051560C Method for preparing chelate of antibiotic and complex metallic salt |
| 04/19/2000 | CN1051559C Novel aminooligosaccharide derivative and process for preparing same |
| 04/19/2000 | CN1051558C Anthracyclie derivatives, prepn. method and use thereof |
| 04/18/2000 | US6051721 Ring E-modified analogues of(-)-podophyllotoxin and etoposide and a method for their synthesis |
| 04/18/2000 | US6051695 Use of a metal alkoxide as the base in the reaction enables etherification to proceed more quickly and at a lower temperature |
| 04/12/2000 | EP0992509A2 Novel macrolide derivatives |
| 04/12/2000 | CN1250054A New tylosin hydroxyl derivative and its producing process |
| 04/11/2000 | CA2090301C New sulfated diosmin derivative |
| 04/11/2000 | CA2011617C 4g.alpha.d-glucopyranosyl rutin, and its preparation and uses |
| 04/05/2000 | EP0990000A1 Connective tissue growth factor-3 |
| 04/05/2000 | EP0989857A1 Novel therapeutic agents that modulate enzymatic processes |
| 04/05/2000 | CN1249309A Gentianate of macrolides antibiotics |
| 04/04/2000 | US6046313 Process for making morphine-6-glucuronide or substituted morphine-6-glucuronide |
| 04/04/2000 | US6046171 6,11-bridged erythromycin derivatives |
| 03/30/2000 | WO2000017218A1 Carbamate and carbazate ketolide antibiotics |
| 03/30/2000 | WO2000017217A1 Process of obtaining genistin-rich isoflavone composition |
| 03/30/2000 | CA2278960A1 Spirocyclic c-glycosides |
| 03/29/2000 | EP0988310A1 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives |
| 03/29/2000 | EP0988309A1 C-4''-substituted macrolide derivatives |
| 03/29/2000 | EP0988308A1 9-oxime erythromycin derivatives |
| 03/29/2000 | EP0988304A1 Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the dna polymerase of hepatitis b virus (hbv) |
| 03/28/2000 | US6043227 C11 carbamates of macrolide antibacterials |
| 03/28/2000 | US6043226 3,6-ketal and enol ether macrolide antibiotics |
| 03/28/2000 | CA2164152C New compounds of the secomacrolide and secoazalide class and a process for the preparation thereof |
| 03/23/2000 | WO2000015647A2 Synthetic method for the preparation of the antineoplastic agent etoposide |
| 03/23/2000 | WO2000015237A1 Composition containing rutin and quercetin for preventing or treating elevated blood lipid level-related diseases |
| 03/23/2000 | WO2000015174A2 Bioflavonoid as blood glucose level lowering agent |
| 03/23/2000 | CA2344054A1 Composition containing rutin and quercetin for preventing or treating elevated blood lipid level-related diseases |
| 03/23/2000 | CA2343803A1 Synthetic method for the preparation of the antineoplastic agent etoposide |